TC BioPharm (Holdings) plc Warrants
N/A
USD
N/A
N/A
...
Chart
Financials
Description
TCBPW Company Description
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
TCBPW Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view TCBPW Smart Score
Score Breakdown
TCBPW Company Description
Show More
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of TCBPW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by TCBPW's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of TCBPW in WallStreetBets Daily Discussion
TCBPW News
Recent insights relating to TCBPW
CNBC Recommendations
Recent picks made for TCBPW stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in TCBPW
Corporate Flights
Flights by private jets registered to TCBPW
Our Analysis